Sudarshan Sukhani of s2analytics.com advised buying Sun Pharma. He also recommended staying long in IDFC on policy day.
Sukhani told CNBC-TV18, “For tomorrow it is wise to remain on the long side so consider buying Sun Pharma. The stock has made a small correction and it has moved up after that correction. It is one of the outstanding stocks in the market. A small correction is what we are getting and it is making life time highs consistently; so be on the long side. The lifetime new highs can again begin tomorrow, buy Sun Pharma.”
He further said, “IDFC has been in an uptrend and that uptrend is intact. A small decline was actually a bullish flag and the stock is now breaking out of the bullish flag resuming its up move. It is one of the better stocks in the infrastructure finance universe; so consider buying IDFC for tomorrow, keep a stop loss because rate sensitive’s can do a lot of unusual things on a bank policy day. But within those constrains, this one is likely to move up; so stay long with it with proper risk management.”
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!